Marco Colonna
Appearances
- DateMay 7, 2023BACKGROUND: Enterochromaffin cells (ECs) are specialized gastrointestinal (GI) epithelial cells that transduce luminal forces and chemicals into release of signal molecules including serotonin (5-HT) to alter GI function including mucosal ion transport…
Presenter
Speaker
- DateMay 19, 2024BACKGROUNDS: Group 3 innate lymphoid cells (ILC3s) have recently emerged as important regulators and potential drug targets for IBD. However, the response of ILC3s to environmental stimuli during intestinal inflammation remains elusive…
Presenter
Speakers
Washington University School of Medicine in St. Louis - DateMay 18, 2024BACKGROUNDS: Perianal fistulas occur in ~30-40% of Crohn’s disease (CD) patients associated with high morbidity and an impaired quality of life. The management of perianal fistulizing CD is a major clinical challenge, where its underlying etiology remains poorly understood…
Presenter
Speakers
- DateMay 18, 2024BACKGROUND & AIMS: After restorative proctocolectomy with ileal pouch-anal anastomosis (IPAA) for ulcerative colitis (UC), a subset of patients develop Crohn’s-like disease of the pouch (CDP), an inflammatory condition that affects both the ileoanal pouch and extra-pouch organs including the pre-po…
Presenter
Speakers
Washington University in St LouisWashington University School of Medicine in St. Louis WESTERN DIET DEPLETES SMALL INTESTINAL INTRAEPITHELIAL LYMPHOCYTES VIA FXR-TYPE I INTERFERON PATHWAY
DateMay 21, 2024Background: The prevalence of obesity has continued to increase over the past several decades. Understanding how diet-induced obesity modulates mucosal immunity is of clinical relevance…- DateMay 19, 2024BACKGROUNDS: Group 2 innate lymphoid cells (ILC2s) are increased in peripheral blood and intestinal samples from patients with ulcerative colitis or Crohn’s disease and murine models of IBD…
Presenter
Speaker